Beta-Peptide Hydrogels for Viable Stem Cell Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing delivery systems for stem cell therapies face challenges such as cell damage during administration, poor integration, and low viability, hindering effective treatment of conditions like ischemic stroke.
Innovation Solution
β-peptides that spontaneously self-assemble into hydrogels, forming a fibrillar network capable of encapsulating therapeutic cargo, including stem cells, to facilitate controlled delivery and improve cell viability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional delivery systems are used for stem cell therapy, then cell administration can be performed, but cell damage occurs during delivery and cell viability decreases
Solution Approach 1:
The patent applies beforehand cushioning by designing a hydrogel delivery system that provides protective cushioning to stem cells before and during the delivery process. The hydrogel matrix acts as a cushioning medium that absorbs mechanical stresses and protects cells from damage during injection and transplantation, thereby maintaining cell viability throughout the delivery process.
Solution Approach 2:
The patent uses hydrogel as an intermediary material between the delivery system and stem cells. The hydrogel serves as a mediator that facilitates gentle cell delivery, providing a biocompatible environment that protects cells from direct contact with harsh delivery conditions while enabling controlled release and integration into host tissue.
2Reliability
If stem cells are delivered to host tissue, then therapeutic benefits can be achieved, but poor integration occurs within the host tissue
Solution Approach 1:
The patent applies parameter changes by modifying the physical and chemical parameters of the delivery system through hydrogel design. The hydrogel's degradation rate, mechanical properties, and molecular weight are optimized to match host tissue characteristics, enabling better cell integration. The system transitions from a foreign delivery vehicle to an integrated part of host tissue as the hydrogel degrades and cells engraft.
3Reliability
If a delivery system is designed to protect cells, then cell viability improves, but the system complexity increases
Solution Approach 1:
The patent applies homogeneity by creating a uniform hydrogel matrix with consistent physical and chemical properties throughout the delivery system. This homogeneous structure provides uniform protection to all embedded cells while simplifying the overall system design, as the single-phase hydrogel material combines multiple protective functions without requiring complex multi-component architectures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The β-peptide hydrogels enhance stem cell delivery by maintaining cell viability and promoting integration within host tissue, thereby improving therapeutic outcomes in stroke treatment.
Implementation Method 1
β-peptides that spontaneously self-assemble in aqueous solution into fibres, leading to the formation of a fibrillar network
Implementation Method 2
leading to the formation of a fibrillar network that absorbs water and forms hydrogels
Data Source
AI summary
The present invention relates to β-peptides and hydrogels comprising the β-peptides. The hydrogels may further comprise a therapeutic cargo encapsulated within the hydrogel. Methods of preparing the hydrogels, and methods for the use of the hydrogels are also described.